Article History
First Online: 14 June 2024
Competing interests
: P.-E.R. has received research funding from Terrafirma and acted as consultant for Hemostod, Mursla, Genfit, Boehringer Ingelheim and Abbelight and received speaker fees from Tillots Pharma and AbbVie. All other authors have no competing interests.